Issue 000 | U.S. Pilot | US

KTTA

Pasithea Therapeutics Corp.

Screen state: Passing Source state: Verified 10-Q | 2026-05-15 Filing currency: USD
Internal NCAV Discount 73.2%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
52,731,456USD
Total Liabilities
1,542,451USD
NCAV
51,189,005USD
Cash
50,400,377USD
NCAV per share
2.05USD/share
Evidence
6 annual | 24 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Not captured in this issue’s Mary run.

This archived issue is not backfilled with observations from a later screening run.

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis

Verified split events: reverse 20.0 on 2021-04-08; reverse 12.0 on 2023-12-28; reverse 20.0 on 2024-01-02

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
Revenue n/a n/a n/a n/a 486,559 15,062
Operating Income -20,857,295 -14,249,962 -14,249,962 -15,979,361 -14,816,321 -4,507,413
Net Income -20,427,683 -13,904,584 -13,904,584 -15,961,658 -13,936,452 -2,173,521
Cash From Operations -15,211,490 -13,923,438 -13,923,438 -12,814,133 -14,561,921 -3,174,058
Capex n/a n/a -34,301 -34,301 -374,889 -21,503
Free Cash Flow n/a n/a -13,957,739 -12,848,434 -14,936,810 -3,195,561
Cash And Equivalents 55,158,939 6,922,729 6,922,729 16,331,052 33,146,895 52,966,706
Accounts Receivable n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Total Current Assets 56,459,084 7,368,315 7,368,315 16,692,154 34,076,693 53,300,457
Total Assets 60,240,070 16,064,719 16,064,719 26,116,858 45,180,089 53,320,581
Total Current Liabilities 4,973,961 1,119,871 1,119,871 2,634,040 1,877,634 447,280
Total Liabilities 5,020,832 1,282,043 1,282,043 2,718,406 2,681,841 1,900,080
Shareholders Equity 55,219,238 14,782,676 14,782,676 23,398,452 42,498,248 51,420,501
Shares Outstanding 23,091,062 1,394,263 1,394,263 1,041,582 26,043,406 23,008,371
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 7,031,050 1,096,082 1,096,082 1,226,600 25,251,756 10,404,668
Weighted Avg Shares Basic 7,031,050 1,096,082 1,096,082 1,226,600 25,251,756 10,404,668
Net Share Count Change (Normalized) 210.2% 33.4% 33.4% 1099.7% -1.9% 74.2%
Ownership Claim Change (Normalized) -67.8% -25.1% -25.1% -91.7% 1.9% -42.6%
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-09-30
10-Q
USD
2021-09-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 13,658 240,712 218,608 13,581 13,658 n/a n/a
Operating Income -4,876,644 -10,256,162 -10,256,162 -3,110,055 -3,810,899 -3,680,179 -3,259,550 -3,259,550 -3,004,604 -3,004,604 -3,945,034 -3,945,034 -4,040,774 -4,040,774 -5,148,782 -3,789,326 -3,828,701 -3,212,552 -5,080,877 -4,250,813 -3,080,094 -2,404,537 n/a -1,273,600
Net Income -2,869,482 -10,110,868 -10,110,868 -3,037,420 -3,716,157 -3,563,238 -3,177,661 -3,177,661 -2,999,834 -2,999,834 -3,866,249 -3,866,249 -3,860,840 -3,860,840 -5,048,159 -3,612,590 -3,763,230 -3,537,679 -5,117,688 -4,586,130 -2,658,394 -1,574,240 n/a -1,526,108
Cash From Operations -4,787,220 -5,396,822 -5,396,822 -2,890,025 -3,868,886 -3,055,757 -2,443,036 -2,443,036 -3,120,451 -3,120,451 -4,038,866 -4,038,866 -4,321,085 -4,321,085 -3,294,344 -3,237,845 -3,079,666 -3,202,278 -4,418,691 -5,238,722 -2,377,030 -2,527,478 n/a n/a
Capex n/a n/a n/a n/a n/a n/a n/a n/a n/a 22,659 n/a -3,108 n/a -53,888 36 22,659 -3,108 -53,888 -25,265 -197,447 -38,310 -113,867 n/a n/a
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a n/a -3,097,792 n/a -4,041,974 n/a -4,374,973 -3,294,308 -3,215,186 -3,082,774 -3,256,166 -4,443,956 -5,436,169 -2,415,340 -2,641,345 n/a n/a
Cash And Equivalents 50,400,377 55,158,939 55,158,939 4,122,953 7,217,052 5,341,278 6,922,729 6,922,729 9,361,169 9,361,169 7,967,569 7,967,569 12,009,347 12,009,347 16,331,052 19,584,690 26,647,633 29,914,063 33,146,895 42,398,233 47,940,075 50,321,206 20,565,319 20,565,319
Total Current Assets 52,731,456 56,459,084 56,459,084 5,529,226 8,636,599 6,124,940 7,368,315 7,368,315 9,778,772 9,778,772 8,642,465 8,642,465 13,192,898 13,192,898 16,692,154 20,771,268 28,036,901 31,113,317 34,076,693 44,469,392 48,614,283 50,949,946 21,033,846 21,033,846
Total Liabilities 1,542,451 5,020,832 5,020,832 1,423,982 1,830,697 1,680,199 1,282,043 1,282,043 823,975 823,975 1,488,124 1,488,124 2,524,630 2,524,630 2,718,406 2,283,805 2,559,197 2,909,790 2,681,841 2,819,488 1,554,160 1,101,187 4,567,296 4,567,296
Shares Outstanding 24,939,948 23,091,062 23,091,062 7,443,577 7,443,577 2,705,263 1,394,263 1,394,263 1,044,914 1,044,914 1,044,081 1,044,081 1,043,248 1,043,248 1,041,582 20,836,623 26,143,407 26,126,740 26,043,406 26,548,688 26,698,688 23,008,371 13,208,371 13,208,371
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 24,337,812 7,031,050 12,708,279 7,443,577 5,641,251 2,211,207 1,096,082 1,253,237 1,044,144 1,044,144 1,043,312 1,043,312 1,042,479 1,042,479 1,226,600 25,160,994 26,128,022 26,073,036 27,937,413 26,548,688 23,444,135 23,008,371 8,956,197 8,956,197
Weighted Avg Shares Basic 24,337,812 7,031,050 12,708,279 7,443,577 5,641,251 2,211,207 1,096,082 1,253,237 1,044,144 1,044,144 1,043,312 1,043,312 1,042,479 1,042,479 1,226,600 25,160,994 26,128,022 26,073,036 27,937,413 26,548,688 23,444,135 23,008,371 8,956,197 8,956,197
Net Share Count Change (Normalized) 8.0% 210.2% 210.2% 0.0% 175.2% 94.0% 33.4% 33.4% 0.1% 0.1% 0.1% 0.1% 0.2% 0.2% 1099.7% -20.3% 0.1% 0.3% -1.9% -0.6% Insufficient evidence 121.1% Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) -7.4% -67.8% -67.8% 0.0% -63.7% -48.5% -25.1% -25.1% -0.1% -0.1% -0.1% -0.1% -0.2% -0.2% -91.7% 25.5% -0.1% -0.3% 1.9% 0.6% Insufficient evidence -54.8% Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 52,731,456USD us-gaap:AssetsCurrent 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Total Liabilities 1,542,451USD us-gaap:Liabilities 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Cash 50,400,377USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Shares Outstanding 24,939,948 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
NCAV 51,189,005USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 2.05USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 73.2% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001841330
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001841330/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
20
Imported At
2026-08-15T12:52:20+00:00
Rendered At
2026-08-16T03:29:34+00:00

Run Audit

Mary Run
1ec055d81d1a42a39490a83bb9e1f22f
Mary As Of
2026-07-03
Accession
0001213900-26-057837
CIK
0001841330
Mary Filing Date
2026-05-15
Filing Currency
USD
Internal Discount
73.2%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-15; mary_accession=0001213900-26-057837; mary_cik=0001841330; gnni_supporting_filing_date=2026-05-15; internal_discount=0.732033; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive